Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006142 · ClinicalTrials.gov registry record · NA
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
A NA study of Upper Endoscopy and GLP1-R-related Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07006142: Recruiting NA study of Upper Endoscopy and GLP1-R-related Disease, sponsored by Mayo Clinic.
NCT07006142 is a NA study of Upper Endoscopy and GLP1-R-related Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07006142, a NA study of Upper Endoscopy and GLP1-R-related Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Primary Outcome
Number of patients who were found to have gastric contents within the stomach during the upper endoscopy.
Conditions Studied
Interventions
- OTHER Modified Fasting Guidelines
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT07006142 shows while recruiting
NCT07006142 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Upper Endoscopy appearing as the primary indexed condition, and to 1 intervention - of which Modified Fasting Guidelines is the first listed.
NCT07006142 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07006142 about?
NCT07006142 is a clinical study titled "Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists". The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
What is the current status of trial NCT07006142?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-08-01. Estimated completion is 2026-04-30.
What conditions does trial NCT07006142 study?
This clinical trial studies the following conditions: Upper Endoscopy, GLP1-R-related Disease.
What interventions are being tested in trial NCT07006142?
The interventions under investigation include: Modified Fasting Guidelines (OTHER).
Who is sponsoring clinical trial NCT07006142?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006142 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07006142's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI